MP ICT at Dr. Essa Lab

MP ICT at Dr. Essa Lab

The Malaria Parasite Immunochromatographic Test, widely known as the MP ICT, is a rapid, highly sensitive, and qualitative diagnostic assay designed to detect specific antigens produced by malaria parasites in human whole blood. Malaria remains a major public health challenge in tropical and subtropical regions, including Pakistan. Caused by protozoan parasites of the genus Plasmodium and transmitted through the bite of infected female Anopheles mosquitoes, malaria requires prompt diagnosis and immediate therapeutic intervention to prevent severe, life-threatening complications. Dr. Essa Lab, a pioneer in diagnostic medicine in Pakistan, offers the MP ICT as a rapid triage and diagnostic tool to facilitate timely clinical decision-making.

The MP ICT works on the principle of lateral flow immunochromatography. The test cassette contains a membrane strip pre-coated with monoclonal antibodies directed against specific malaria antigens. The primary antigens targeted are Histidine-Rich Protein II (HRP-2), which is highly specific to Plasmodium falciparum, and parasite Lactate Dehydrogenase (pLDH) or aldolase, which are common to all major human malaria species (Plasmodium vivax, Plasmodium malariae, and Plasmodium ovale). When a small sample of the patient's blood is mixed with a lysis buffer and applied to the test strip, the red blood cells rupture, releasing intracellular parasite antigens. These antigens bind to gold-conjugated antibodies on the strip, migrating upward via capillary action. If malaria antigens are present, they bind to the capture antibodies on the test and control lines, producing visible colored bands. This rapid technology allows clinicians to obtain diagnostic results within minutes, bypassing the time-consuming preparation required for traditional microscopy.

The clinical importance of the MP ICT lies in its ability to quickly differentiate between Plasmodium falciparum and non-falciparum species, particularly Plasmodium vivax, which are the two most prevalent species in Pakistan. Plasmodium falciparum is notorious for causing severe malaria, which can rapidly progress to cerebral malaria, severe hemolytic anemia, acute kidney injury, or multi-organ failure. By providing a rapid and clear distinction, the MP ICT at Dr. Essa Lab enables healthcare providers to initiate targeted antimalarial therapies, such as Artemisinin-based Combination Therapies (ACTs) for P. falciparum or chloroquine/primaquine regimens for P. vivax, thereby optimizing patient outcomes and reducing the risk of drug resistance.

Clinical Procedure: What to Expect

Patient Preparation

The MP ICT is a straightforward blood test that requires minimal preparation. To ensure an accurate and seamless testing process, patients are advised to follow these preparation guidelines:

• No Fasting Required: Unlike many metabolic blood tests, you do not need to fast before undergoing an MP ICT. You can eat and drink normally prior to your appointment.
• Medication Disclosure: Inform your physician and the laboratory staff if you have recently taken or are currently taking any antimalarial medications, antibiotics, or fever-reducing drugs, as these can influence parasite load and test sensitivity.
• Hydration: Drink plenty of water before the test. Being well-hydrated makes your veins more accessible, facilitating an easier and quicker blood draw.
• Comfortable Clothing: Wear a loose-fitting or short-sleeved shirt to allow easy access to your arm's cubital fossa (the inner elbow area).

During the Procedure

The collection of a blood sample for the MP ICT at Dr. Essa Lab is conducted by highly trained phlebotomists adhering to strict aseptic techniques. The procedure involves the following steps:

• Sanitization and Setup: The phlebotomist cleanses the skin over the selected vein (usually the median cubital vein in the arm) using a 70% isopropyl alcohol swab and allows it to air dry to prevent contamination.
• Tourniquet Application: A soft elastic tourniquet is tied around the upper arm to increase venous pressure, making the veins more prominent and easier to palpate.
• Venipuncture: A sterile, single-use needle attached to a vacuum collection tube (typically an EDTA tube, which prevents blood clotting) is gently inserted into the vein. You may feel a brief, minor prick or pinch.
• Sample Collection: The required volume of blood (usually a few milliliters) is drawn into the tube. For rapid point-of-care testing, a finger-prick capillary sample may occasionally be utilized depending on the specific clinical protocol.
• Post-Draw Care: The tourniquet is released, the needle is smoothly withdrawn, and a sterile cotton ball or gauze pad is pressed onto the puncture site to stop any minor bleeding. A small adhesive bandage is then applied.
• Test Execution: In the laboratory, a precise volume of the collected blood (usually 5 to 10 microliters) is dispensed into the sample well of the MP ICT cassette, followed by the addition of a specialized assay buffer. The buffer lyses the red blood cells and facilitates the migration of the sample across the immunochromatographic strip.
• Duration and Experience: The blood draw itself takes less than two minutes. The immunochromatographic reaction takes approximately 15 to 20 minutes to develop fully, after which the results are read and verified by a consultant pathologist.

When is a MP ICT Performed?

Acute Febrile Illness with Chills and Rigors

Physicians routinely order the MP ICT when a patient presents with an acute, unexplained fever accompanied by classic malarial paroxysms, including intense shivering (rigors), high body temperature, and profuse sweating. These symptoms correspond to the synchronous rupture of infected red blood cells and the release of merozoites into the bloodstream. Rapid testing is crucial during these febrile episodes to confirm or rule out malaria as the primary cause.

Travel History to Malaria-Endemic Regions

Individuals who have recently traveled to or returned from rural, agricultural, or heavily forested areas known for high malaria transmission are highly susceptible to infection. If such individuals develop fever, severe headaches, or flu-like symptoms within weeks or even months of travel, clinicians utilize the MP ICT to rapidly screen for malaria, ensuring that imported cases are identified and treated immediately to prevent local transmission cycles.

Monitoring Treatment Efficacy in Malaria Patients

While microscopy remains the gold standard for quantifying parasite clearance, the MP ICT can assist in monitoring clinical progress. Specifically, tests targeting the parasite Lactate Dehydrogenase (pLDH) enzyme are highly useful because pLDH is only produced by living, metabolically active parasites. A decline or disappearance of the pLDH band during or after treatment indicates successful parasite clearance, whereas its persistence suggests treatment failure or drug resistance.

Differential Diagnosis of Undifferentiated Tropical Fevers

In regions where multiple infectious diseases coexist, patients presenting with fever, muscle pain, and fatigue can pose a diagnostic challenge. Clinicians request the MP ICT to differentiate malaria from other prevalent tropical diseases such as dengue fever, typhoid (enteric fever), leptospirosis, and viral influenza. A rapid positive or negative malaria antigen result helps narrow down the differential diagnosis, preventing unnecessary antibiotic use and ensuring appropriate therapy.

Screening in High-Risk or Immunocompromised Individuals

Certain patient populations, including pregnant women, young children, and individuals with compromised immune systems (such as those with HIV or undergoing chemotherapy), are at an exceptionally high risk for rapid clinical deterioration if they contract malaria. In these vulnerable groups, even mild or atypical symptoms warrant immediate investigation with the MP ICT to prevent severe maternal-fetal complications, severe anemia, or cerebral involvement.

What Does a MP ICT Detect?

The MP ICT is designed to identify specific biochemical markers produced by the malaria parasite. The test detects and clinically correlates several key parameters:

• Histidine-Rich Protein II (HRP-2): A water-soluble protein synthesized and secreted by Plasmodium falciparum. It is highly stable and serves as a primary marker for detecting active or very recent P. falciparum infections.
• Parasite Lactate Dehydrogenase (pLDH): A glycolytic enzyme produced in large quantities by viable, actively replicating malaria parasites. It is used to detect all four major human-infecting species of Plasmodium.
• Pan-Specific Aldolase: An enzyme shared across all Plasmodium species, serving as a reliable pan-malarial marker to confirm the presence of any malaria parasite.
• Plasmodium falciparum Specificity: The presence of a distinct HRP-2 band confirms that the infection is caused by P. falciparum, the most dangerous malaria species.
• Non-Falciparum Species Presence: A positive pan-specific band (pLDH or aldolase) combined with a negative HRP-2 band indicates an infection caused by P. vivax, P. malariae, or P. ovale.
• Mixed Plasmodium Infections: Simultaneous visualization of both the P. falciparum-specific band and the pan-malarial band indicates a mixed infection, typically involving both P. falciparum and P. vivax.
• Active Parasitemia vs. Cleared Infection: Because pLDH is cleared rapidly from the bloodstream once the parasites die, a positive pLDH test strongly correlates with active, living parasites, whereas HRP-2 can persist for weeks after successful cure.
• Low-Density Parasitemia Limitations: The test detects the presence of antigens down to a threshold of approximately 100 to 200 parasites per microliter of blood; levels below this may yield a negative result despite active infection.
• Prozone Effect Interference: In rare cases of extremely high parasitemia, an excess of antigen can saturate the test antibodies, leading to a false-negative or weakly positive result.
• Rheumatoid Factor (RF) Cross-Reactivity: High levels of autoantibodies, such as Rheumatoid Factor, can occasionally cause false-positive HRP-2 results by cross-linking the capture and detection antibodies.
• Genetic pfhrp2/3 Gene Deletions: Some strains of P. falciparum carry deletions of the genes encoding HRP-2/3, which can lead to false-negative results on HRP-2-based rapid tests.
• Test Strip Validity: Every cassette features an internal control line (C-line) that must turn positive to verify that the sample migrated correctly and that the reagents are functional.

Turnaround Time and Report Access at Dr. Essa Lab

Dr. Essa Lab is committed to delivering highly accurate diagnostic results with the fastest possible turnaround times. Because malaria is a medical emergency that requires immediate clinical action, the MP ICT is treated with high priority. Once the blood sample is collected at any of our state-of-the-art collection centers or through our home sample collection service, it is processed immediately. The technical execution of the test takes under 20 minutes, and the final report is typically verified by our consultant pathologists and made available within a few hours.

Patients can easily access their diagnostic reports online through the official Dr. Essa Lab web portal. Upon completion of the test, an automated SMS notification containing a direct, secure link to download the PDF report is sent to the patient's registered mobile number. Physical copies of the report can also be collected from the respective branch where the sample was registered. This seamless digital integration ensures that patients and their attending physicians receive critical diagnostic data without delay, facilitating immediate therapeutic intervention.

MP ICT Findings Overview

The following table provides an overview of the clinical parameters evaluated during an MP ICT and their corresponding interpretations:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Control Line (C-Line)	Visible colored band (Valid test run)	No band visible (Invalid test; requires immediate retesting)
Plasmodium falciparum Antigen (HRP-2)	Negative (No band visible)	Positive (Visible band; indicates active or recent P. falciparum infection)
Pan-Malarial Antigen (pLDH / Aldolase)	Negative (No band visible)	Positive (Visible band; indicates infection with P. vivax, P. malariae, or P. ovale)
Mixed Infection Marker	Negative (Only one species line visible)	Positive (Both P. falciparum and pan-specific lines visible; indicates co-infection)
Parasite Viability Status	Negative (No active replication)	Positive pLDH (Indicates viable, actively replicating malaria parasites)
Post-Treatment Antigen Persistence	Negative (Antigens cleared)	Positive HRP-2 with negative pLDH (Suggests resolved infection with lingering antigenemia)
Test Validity Check	Valid (Reagents functional)	Invalid (Reagent degradation or insufficient sample volume)

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for MP ICT?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified, board-certified consultant pathologists, microbiologists, and technologists specializing in infectious disease diagnostics.
• Patient-Focused Care: We prioritize patient comfort and safety at every step, ensuring a gentle, hygienic, and professional blood collection experience.
• Quality Diagnostic Services: Dr. Essa Lab adheres to stringent international quality control protocols, ensuring that every test result is highly accurate and clinically reliable.
• Professional Reporting: All reports undergo a rigorous multi-level verification process by senior medical specialists before release.
• Modern Diagnostic Approach: We utilize state-of-the-art diagnostic equipment and high-sensitivity lateral flow assay kits to minimize false-positive and false-negative rates.
• Comfortable Environment: Our diagnostic centers are designed to provide a clean, welcoming, and stress-free environment for patients of all ages.
• Convenient Location: With an extensive network of branches and collection points across Karachi and other major cities, accessing our diagnostic services is highly convenient.
• Commitment to Accurate Diagnosis: Established in 1987, Dr. Essa Lab has built over three decades of trust, consistently delivering excellence in medical diagnostics to the community.